Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
A Bonaventura, A Vecchié, L Dagna… - Nature Reviews …, 2021 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …
Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches
Y Jin, W Ji, H Yang, S Chen, W Zhang… - Signal transduction and …, 2020 - nature.com
On 12 March 2020, the outbreak of coronavirus disease 2019 (COVID-19) was declared a
pandemic by the World Health Organization. As of 4 August 2020, more than 18 million …
pandemic by the World Health Organization. As of 4 August 2020, more than 18 million …
Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin
E Pretorius, M Vlok, C Venter, JA Bezuidenhout… - Cardiovascular …, 2021 - Springer
Background Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-induced
infection, the cause of coronavirus disease 2019 (COVID-19), is characterized by acute …
infection, the cause of coronavirus disease 2019 (COVID-19), is characterized by acute …
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Background Mortality of patients with coronavirus disease 2019 (COVID-19), acute
respiratory distress syndrome (ARDS), and systemic inflammation is high. In areas of …
respiratory distress syndrome (ARDS), and systemic inflammation is high. In areas of …
COVID-19 and multiorgan failure: A narrative review on potential mechanisms
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in
December 2019 form Wuhan, China leads to coronavirus disease 2019 (COVID-19) …
December 2019 form Wuhan, China leads to coronavirus disease 2019 (COVID-19) …
Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series
Background: Coronavirus disease 2019 (COVID-19) caused by the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly become pandemic, with …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly become pandemic, with …
Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers
A Jain, R Chaurasia, NS Sengar, M Singh, S Mahor… - Scientific reports, 2020 - nature.com
COVID-19 is characterized by marked variability in clinical severity. Vitamin D had recently
been reviewed as one of the factors that may affect the severity in COVID-19. The objective …
been reviewed as one of the factors that may affect the severity in COVID-19. The objective …
Thrombosis in COVID‐19
Thrombotic complications are frequent in COVID‐19 and contribute significantly to mortality
and morbidity. We review several mechanisms of hypercoagulability in sepsis that may be …
and morbidity. We review several mechanisms of hypercoagulability in sepsis that may be …
New international guidelines and consensus on the use of lung ultrasound
Following the innovations and new discoveries of the last 10 years in the field of lung
ultrasound (LUS), a multidisciplinary panel of international LUS experts from six countries …
ultrasound (LUS), a multidisciplinary panel of international LUS experts from six countries …
The potential of working hypotheses for deductive exploratory research
While hypotheses frame explanatory studies and provide guidance for measurement and
statistical tests, deductive, exploratory research does not have a framing device like the …
statistical tests, deductive, exploratory research does not have a framing device like the …